Skip to main content
. 2000 Apr 25;97(10):5580–5585. doi: 10.1073/pnas.090464197

Table 3.

Immunoreactive IL-1β levels

Treatment Striatum Cortex Hypothalamus
After 3 h
 Sham ND ND ND
 Vehicle 32  ± 4 28  ± 1 20  ± 3
 S-AMPA 28  ± 6 86  ± 23 26  ± 7
 hrIL-1β 29  ± 3 56  ± 20 41  ± 4
 S-AMPA + hrIL-1β 47  ± 9 128  ± 27* 56  ± 9**,
After 8 h
 Sham ND ND ND
 Vehicle 157  ± 46 65  ± 20 18  ± 3
 S-AMPA 48  ± 7 72  ± 10 35  ± 7
 hrIL-1β 304  ± 70††,‡ 147  ± 41 128  ± 30**,†,‡
 S-AMPA + hrIL-1β 241  ± 34†,‡‡ 870  ± 186***,†††,‡,§§§ 186  ± 27***,†††,‡

Expression of immunoreactive rat IL-1β (pg IL-1β/mg protein) in different regions of the rat brain 3 h and 8 h after intrastriatal injection (n = 4–6) of vehicle, S-AMPA (7.5 nmol), hrIL-1β (10 ng) or S-AMPA (7.5 nmol) + hrIL-1β (10 ng). ∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗, P < 0.001 vs. vehicle. †, P < 0.05, ††, P < 0.01, †††, P < 0.001 vs. S-AMPA. ‡, P < 0.05; ‡‡, P < 0.01 vs. 3 h; §§§, P < 0.001 vs. hrIL-1β. ND, not detectable.